share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kulkarni Samarth

CRISPR Therapeutics | 4：持股變動聲明-高管 Kulkarni Samarth

SEC announcement ·  02/22 06:52
牛牛AI助理已提取核心訊息
CRISPR Therapeutics AG's CEO, Samarth Kulkarni, completed a sale of 6,370 common shares on February 20, 2024, as per the latest SEC filings. The shares were sold at a price of $79.67 each, totaling approximately $507,498 in value. Prior to this sale, Kulkarni exercised options to acquire 13,250 shares on February 18, 2024, under a transaction classified as an exercise or conversion of derivative security. Following these transactions, Kulkarni directly holds 194,257 shares of the company. Additionally, Kulkarni has an indirect beneficial ownership of 200,000 shares through The Kulkarni 2023 GRAT, an indirect holding entity.
CRISPR Therapeutics AG's CEO, Samarth Kulkarni, completed a sale of 6,370 common shares on February 20, 2024, as per the latest SEC filings. The shares were sold at a price of $79.67 each, totaling approximately $507,498 in value. Prior to this sale, Kulkarni exercised options to acquire 13,250 shares on February 18, 2024, under a transaction classified as an exercise or conversion of derivative security. Following these transactions, Kulkarni directly holds 194,257 shares of the company. Additionally, Kulkarni has an indirect beneficial ownership of 200,000 shares through The Kulkarni 2023 GRAT, an indirect holding entity.
根據美國證券交易委員會的最新文件，CRISPR Therapeutics AG的首席執行官薩瑪斯·庫爾卡尼於2024年2月20日完成了6,370股普通股的出售。這些股票以每股79.67美元的價格出售，總價值約爲507,498美元。在此次出售之前，庫爾卡尼根據一項被歸類爲行使或轉換衍生證券的交易，於2024年2月18日行使了期權收購了13,250股股票。在這些交易之後，庫爾卡尼直接持有該公司194,257股股份。此外，庫爾卡尼通過間接控股實體庫爾卡尼2023 GRAT擁有20萬股股票的間接實益所有權。
根據美國證券交易委員會的最新文件，CRISPR Therapeutics AG的首席執行官薩瑪斯·庫爾卡尼於2024年2月20日完成了6,370股普通股的出售。這些股票以每股79.67美元的價格出售，總價值約爲507,498美元。在此次出售之前，庫爾卡尼根據一項被歸類爲行使或轉換衍生證券的交易，於2024年2月18日行使了期權收購了13,250股股票。在這些交易之後，庫爾卡尼直接持有該公司194,257股股份。此外，庫爾卡尼通過間接控股實體庫爾卡尼2023 GRAT擁有20萬股股票的間接實益所有權。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。